Cargando…

Therapeutic Outcome of Second Primary Malignancies in Patients with Well-Differentiated Thyroid Cancer

Background. The aims of this study were to analyze the clinical characteristics of SPM in patients with well-differentiated thyroid cancer and to determine the long-term prognosis in patients with double malignancies. Materials and Methods. We retrospectively analyzed 2,864 patients with well-differ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liou, Miaw-Jene, Tsang, Ngan-Ming, Hsueh, Chuen, Chao, Tzu-Chieh, Lin, Jen-Der
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828550/ https://www.ncbi.nlm.nih.gov/pubmed/27118971 http://dx.doi.org/10.1155/2016/9570171

Ejemplares similares

Circulating epithelial cell counts for monitoring the therapeutic outcome of patients with papillary thyroid carcinoma
por: Tseng, Ching-Ping, et al.
Publicado: (2017)

Long-Term Follow-Up of the Therapeutic Outcomes for Papillary Thyroid Carcinoma With Distant Metastasis
por: Lin, Jen-Der, et al.
Publicado: (2015)

Gender-Specific Variation in the Prognosis of Papillary Thyroid Cancer TNM Stages II to IV
por: Hsieh, Sheng-Hwu, et al.
Publicado: (2012)

Prognosis of Multifocal Papillary Thyroid Carcinoma
por: Kuo, Sheng-Fong, et al.
Publicado: (2013)

Soft tissue invasion of papillary thyroid carcinoma
por: Lin, Jen-Der, et al.
Publicado: (2016)

Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis
por: Liu, Feng‐Hsuan, et al.
Publicado: (2015)

Disease-Specific Mortality and Secondary Primary Cancer in Well-Differentiated Thyroid Cancer with Type 2 Diabetes Mellitus
por: Chen, Szu-Tah, et al.
Publicado: (2013)

Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: A single-center observational study in Taiwan
por: Sun, Jui-Hung, et al.
Publicado: (2022)

Combined analysis of circulating epithelial cells and serum thyroglobulin for distinguishing disease status of the patients with papillary thyroid carcinoma
por: Lin, Hung-Chih, et al.
Publicado: (2015)

Long-term follow-up of papillary and follicular thyroid carcinomas with bone metastasis
por: Lin, Jen-Der, et al.
Publicado: (2017)

Using Deep Convolutional Neural Networks for Enhanced Ultrasonographic Image Diagnosis of Differentiated Thyroid Cancer
por: Chan, Wai-Kin, et al.
Publicado: (2021)

Clinical Outcomes of Patients with Resected Oral Cavity Cancer and Simultaneous Second Primary Malignancies
por: Liao, Chun-Ta, et al.
Publicado: (2015)

Second primary malignancy risk after radiotherapy in rectal cancer survivors
por: Wang, Ti-Hao, et al.
Publicado: (2018)

Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas and Larger Tumors
por: Ng, Soh-Ching, et al.
Publicado: (2017)

Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal
por: Tsai, Hsi-Chen, et al.
Publicado: (2022)

Successful Applications of Food-Assisted and -Simulated Training Model of Thyroid Radiofrequency Ablation
por: Li, Yan-Rong, et al.
Publicado: (2022)

Activity of roniciclib in medullary thyroid cancer
por: Lin, Shu-Fu, et al.
Publicado: (2018)

Diagnostic pitfalls and therapeutic outcomes of the macrofollicular variant of papillary thyroid carcinoma
por: Ng, Soh-Ching, et al.
Publicado: (2019)

Long-term therapeutic outcomes of papillary thyroid carcinoma with concomitant hyperparathyroidism: A single center case-control study
por: Tsai, Chih-Yiu, et al.
Publicado: (2020)

Effects of roniciclib in preclinical models of anaplastic thyroid cancer
por: Lin, Shu-Fu, et al.
Publicado: (2017)

Second primary malignancies after treatment for malignant lymphoma
por: Okines, A, et al.
Publicado: (2005)

A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer
por: Lin, Shu-Fu, et al.
Publicado: (2017)

Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential
por: Lamba Saini, Monika, et al.
Publicado: (2015)

Quantitative differentiation of malignant and benign thyroid nodules with multi-parameter diffusion-weighted imaging
por: Zhu, Xiang, et al.
Publicado: (2022)

The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis
por: Lin, Jen-Der, et al.
Publicado: (2018)

Second primary malignancies in thyroid cancer patients
por: Rubino, C, et al.
Publicado: (2003)

Prevalence and treatment outcomes of second primary malignancies in Saudi patients with differentiated thyroid cancers
por: Al-Qahtani, Khalid H., et al.
Publicado: (2015)

Differentiated Thyroid Cancer with Extrathyroidal Extension: Prognosis and the Role of External Beam Radiotherapy
por: Sia, Michael A., et al.
Publicado: (2010)

Does Radioiodine Therapy in Patients with Differentiated Thyroid Cancer Increase the Frequency of Another Malignant Neoplasm?
por: Hirosawa, Renata Midori, et al.
Publicado: (2011)

Neck Surgery for Non-Well Differentiated Thyroid Malignancies: Variations in Strategy According to Histopathology
por: López, Fernando, et al.
Publicado: (2023)

Higher body weight and distant metastasis are associated with higher radiation exposure to the household environment from patients with thyroid cancer after radioactive iodine therapy
por: Kuo, Sheng-Fong, et al.
Publicado: (2017)

Non-thyroidal second primary malignancy in papillary thyroid cancer patients
por: Borges Duarte, Diana, et al.
Publicado: (2022)

Primary lung cancer with radioiodine avidity: A thyroid cancer cohort study
por: Lu, Yu-Ling, et al.
Publicado: (2021)

Risk Factors for Nonsynchronous Second Primary Malignancy and Related Death in Patients with Differentiated Thyroid Carcinoma
por: Lang, Brian Hung-Hin, et al.
Publicado: (2011)

Role of Multiparameter Analysis of AgNORs in FNA Smears of Thyroid Swellings in Differentiating Benign and Malignant Lesions
por: Hossain, Mohammad Ismail, et al.
Publicado: (2012)

Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models
por: Lin, Shu-Fu, et al.
Publicado: (2017)

Utility of a PI3K/mTOR Inhibitor (NVP-BEZ235) for Thyroid Cancer Therapy
por: Lin, Shu-Fu, et al.
Publicado: (2012)

Risk Factors Associated with Benign and Malignant Thyroid Nodules in Autoimmune Thyroid Diseases
por: Lima, Priscila Carneiro Moreira, et al.
Publicado: (2013)

Patient outcomes following surgical management of multinodular goiter: Does multinodularity increase the risk of thyroid malignancy?
por: Lin, Yann-Sheng, et al.
Publicado: (2016)

Second malignancies in patients with differentiated thyroid carcinoma treated with low and medium activities of radioactive I-131
por: PICIU, DOINA, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gvoignki71t0f0lmkjemb7m5v1